Patent expiry dates for best-selling biologicals - GaBI Journal
Top 5 expired blockbuster drugs - Clinical Trials Arena
India's drug industry to touch $48 billion by 2018
Teva generics revenue by region 2016-2020 | Statista
Drug Patent expiry in 2017 – All About Drugs
Generic drug - Wikipedia
Patexia - Pfizer vs Teva was a big case between generic and brand drugmakers, and was the first time when damages were paid for the creation and selling of a generic brand
Patent expiry dates for biologicals: 2017 update - GaBI Journal
Teva's bid to block generic copaxone rejected
Patent expiry dates for biologicals: 2017 update - GaBI Journal
Monthly price reduction of generic drugs after patent loss U.S. 2015 | Statista
Loss of Patent Protection to Drag Pfizer's Top Line
Time for a Turnaround at Teva Pharmaceuticals Industries Ltd? | The Motley Fool
Patent Docs: Top Drugs Losing Patent Exclusivity in 2021
One, two, three, gone: Teva loses third patent on new Copaxone formula | FiercePharma
Celgene Settles U.S. Patent Litigation for Revlimid | Fortune
Teva and Eagle Allege Infringement of 14 Cancer Drug Patents by Accord's Proposed Generic - IP News Shots
Drug Patent Expirations and the “Patent Cliff”
Court refuses injunctions in pharma patent case
Patent expiry dates for biologicals: 2018 update - GaBI Journal
3 Top Pharmaceuticals: Patents, Pipelines And Prospects | Seeking Alpha
Legitimate patent extension or patent system abuse? | Pharmaceutical Patent Analyst
The top 15 blockbuster patent expirations coming this decade | FiercePharma
Patent expiry dates for biologicals: 2017 update - GaBI Journal
PATENT EXPIRY DATES 1/3 | New Drug Approvals
Patent Loss in Pharma | Tefen Blog
TEVA drug pipeline, global patents
